C57BL/6JCya-Chrnb3em1/Cya
Common Name
Chrnb3-KO
Product ID
S-KO-17177
Backgroud
C57BL/6JCya
Strain ID
KOCMP-108043-Chrnb3-B6J-VB
When using this mouse strain in a publication, please cite “Chrnb3-KO Mouse (Catalog S-KO-17177) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Chrnb3-KO
Strain ID
KOCMP-108043-Chrnb3-B6J-VB
Gene Name
Product ID
S-KO-17177
Gene Alias
5730417K16Rik, Acrb3
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 8
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000060943
NCBI RefSeq
NM_173212
Target Region
Exon 2
Size of Effective Region
~1.7 kb
Overview of Gene Research
Chrnb3, the cholinergic receptor nicotinic beta 3 subunit gene, is a key component of nicotinic acetylcholine receptors (nAChRs), which are ligand-gated ion channels. These receptors play crucial roles in the nervous system, and the pathways they are involved in include those related to neurotransmission. Chrnb3 is of significant biological importance, especially in the context of nicotine-related behaviors and certain neurological functions [1-10]. Genetic models, such as transgenic mouse lines, are valuable for studying its function.
Functional studies in mice have shown that the α6*-nAChRs, in which Chrnb3 is involved, located in the ventral tegmental area (VTA), are important in controlling nicotine self-administration. For example, when the α6 subunit is selectively re-expressed in the VTA of the α6(-/-) mouse by a lentiviral vector, the reinforcing property of nicotine is restored. Also, genetic knock-in strains with replacement of Leu with Ser in the 9' residue in the M2 domain of α6 produce nicotine-hypersensitive mice with enhanced dopamine release [1].
In conclusion, Chrnb3 is essential for the function of nAChRs, especially those in the VTA related to nicotine-induced behaviors. Mouse models, including gene-knockout and knock-in models, have revealed its role in nicotine dependence, and its association with other conditions such as Parkinson's disease, alcohol consumption, and psoriasis vulgaris severity [1,2,3,4]. These findings contribute to our understanding of the biological mechanisms underlying these diseases and potentially offer new directions for treatment.
References:
1. Wen, L, Yang, Z, Cui, W, Li, M D. 2016. Crucial roles of the CHRNB3-CHRNA6 gene cluster on chromosome 8 in nicotine dependence: update and subjects for future research. In Translational psychiatry, 6, e843. doi:10.1038/tp.2016.103. https://pubmed.ncbi.nlm.nih.gov/27327258/
2. Bar-Shira, Anat, Gana-Weisz, Mali, Gan-Or, Ziv, Giladi, Nir, Orr-Urtreger, Avi. 2014. CHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking. In Neurobiology of aging, 35, 2179.e1-6. doi:10.1016/j.neurobiolaging.2014.03.014. https://pubmed.ncbi.nlm.nih.gov/24731518/
3. Hoft, N R, Corley, R P, McQueen, M B, Menard, S, Ehringer, M A. 2009. SNPs in CHRNA6 and CHRNB3 are associated with alcohol consumption in a nationally representative sample. In Genes, brain, and behavior, 8, 631-7. doi:10.1111/j.1601-183X.2009.00495.x. https://pubmed.ncbi.nlm.nih.gov/19500157/
4. Zhu, Kun-Ju, Quan, Cheng, Zhang, Chi, Li, Ke-Shen, Fan, Yi-Ming. 2014. Combined effect between CHRNB3-CHRNA6 region gene variant (rs6474412) and smoking in psoriasis vulgaris severity. In Gene, 544, 123-7. doi:10.1016/j.gene.2014.04.070. https://pubmed.ncbi.nlm.nih.gov/24792900/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
